Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorShanghai Pulmonary Hospital, Shanghai, China
About this trial
This study aims to design and conduct a multicenter, prospective, randomized controlled post-market clinical trial to validate the clinical efficacy of high-precision electromagnetic navigation technology.
Eligibility criteria
Qualifiers
Age 18-80 years, regardless of gender;
Solitary single nodule, scheduled for lung nodule puncture and localization;
Chest CT (lung window mode) showing a maximum nodule diameter ≤ 2 cm;
Eastern Cooperative Oncology Group (ECOG) performance status score 0-2;
Disqualifiers
Not suitable for video-assisted thoracoscopic surgery;
The distance between the center of the lesion and the dome of the diaphragm is < 3 cm;
History of thoracic adhesion due to previous thoracotomy or pleural infection;
Patients judged by the investigator to be unsuitable for preoperative transthoracic or transbronchial localization;
Trial design
Treatments tested in this trial
- Electromagnetic Navigation-Guided Percutaneous Localization of Pulmonary Nodules
- CT-Guided Percutaneous Localization of Pulmonary Nodules
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov